Surgeons Are Closer to Predicting Which Patients Need Post-Surgery Opioids—and Which Ones Don’t
Opioids are routinely prescribed to patients after a surgery—whether they use them or not. A new study, led by LDI Senior Fellow Anish Agarwal will help tailor prescribing so patients get the right amount of opioid medications; not too little and not too much. Unused opioids are a particular problem. Opioid misuse can start when extra tablets […]
Incentivizing Recovery: Payment, Policy, and Implementation of Contingency Management
On January 19th, 2024, CHERISH and the University of Pennsylvania’s Leonard Davis Institute of Health Economics (LDI), co-hosted a virtual convening titled Incentivizing Recovery: Payment, Policy, and Implementation of Contingency Management. Contingency management is a proven and promising treatment for specific substance use disorders, especially stimulant use disorder. However, significant gaps in knowledge regarding the […]
Economic benefits of substance use disorder treatment: A systematic literature review of economic evaluation studies from 2003 to 2021
The economic burden of substance use disorder (SUD) is significant. It encompasses clinical and societal costs such as health care and social services, criminal justice resources, loss of productivity, and premature mortality, and is estimated to cost more than $700 billion per year in the United States. To understand the gravity of these economic costs, […]
Why Does the Opioid Mortality Rate Continue to Rise?
From April 2020 through April 2021, there were 100,300 drug overdose deaths across the country according to the CDC — a 28.5% increase over the previous year. Some 75% of these were opioid-related overdoses that killed an average of nine users an hour around the clock throughout the year. Looking forward, the just-published Stanford-Lancet Commission on […]
Engage with CHERISH
Submit a Consultation Request or Contact Us to learn more about how CHERISH can support your research or policy goals.